Jade Biosciences (JBIO) Non-Current Assets (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Non-Current Assets data on file, last reported at $916000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 472.5% year-over-year to $916000.0; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (down 13.89% YoY), and the FY2025 full-year result was $965000.0, down 69.32% from the prior year.
• Non-Current Assets for Q1 2026 stood at $916000.0, down from $965000.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $3.8 million in Q1 2023 and bottomed at $160000.0 in Q1 2025.
• The 5-year median for Non-Current Assets is $2.2 million (2022), against an average of $2.1 million.
• The widest annual swing landed in 2025, when Non-Current Assets slumped 95.53%; it then jumped 472.5% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $3.8 million in 2022, then decreased by 16.27% to $3.2 million in 2023, then fell by 1.29% to $3.1 million in 2024, then sank by 69.32% to $965000.0 in 2025, then decreased by 5.08% to $916000.0 in 2026.
• The last three Non-Current Assets figures came in at $916000.0 (Q1 2026), $965000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison